Literature DB >> 15858273

Structure of human thymidylate synthase under low-salt conditions.

Leslie L Lovelace1, Wladek Minor, Lukasz Lebioda.   

Abstract

Human thymidylate synthase, a target in cancer chemotherapy, was crystallized from PEG 3350 with 30 mM ammonium sulfate (AS) in the crystallization medium. The crystals are isomorphous with the high-salt crystals ( approximately 2.0 M AS) and the structure has been solved and refined (R = 22.6%, R(free) = 24.3%) at 1.8 A resolution. The high- and low-AS-concentration structures are quite similar, with loop 181-197 is in the inactive conformation. Also, residues 95-106 and 129-135 (eukaryotic inserts region) show high mobility as assessed by poor electron density and high values of crystallographic temperature factors (residues 1-25 and 108-129 are disordered in both structures). The high mobility of this region may reflect the situation at physiological ionic strength. Of the four sulfate ions observed bound at 2.0 M AS, only two are present at 30 mM AS. The inactive conformation appears to be stabilized by the side chain of Val3 or a leucine residue from the disordered regions. The low-salt conditions of these crystals should be much more suitable for the study of thymidylate synthase inhibitors, especially those that utilize sulfate-binding sites to stabilize the inactive conformation of loop 181-197.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858273     DOI: 10.1107/S0907444905005895

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  16 in total

1.  Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.

Authors:  Dan Chen; Anna Jansson; Daniel Sim; Andreas Larsson; Pär Nordlund
Journal:  J Biol Chem       Date:  2017-06-20       Impact factor: 5.157

2.  The R163K mutant of human thymidylate synthase is stabilized in an active conformation: structural asymmetry and reactivity of cysteine 195.

Authors:  Lydia M Gibson; Leslie L Lovelace; Lukasz Lebioda
Journal:  Biochemistry       Date:  2008-03-28       Impact factor: 3.162

3.  Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation.

Authors:  Leslie L Lovelace; Saphronia R Johnson; Lydia M Gibson; Brittnaie J Bell; Sondra H Berger; Lukasz Lebioda
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

4.  Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors.

Authors:  Victor G Ruiz; Daniel J Czyzyk; Vidya P Kumar; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2020-05-30       Impact factor: 2.823

5.  Evolution of metamorphism in thymidylate synthases within the primate lineages.

Authors:  BeiBei Luo; Saphronia R Johnson; Lukasz Lebioda; Sondra H Berger
Journal:  J Mol Evol       Date:  2011-02-12       Impact factor: 2.395

6.  Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.

Authors:  Daniela Cardinale; Giambattista Guaitoli; Donatella Tondi; Rosaria Luciani; Stefan Henrich; Outi M H Salo-Ahen; Stefania Ferrari; Gaetano Marverti; Davide Guerrieri; Alessio Ligabue; Chiara Frassineti; Cecilia Pozzi; Stefano Mangani; Dimitrios Fessas; Remo Guerrini; Glauco Ponterini; Rebecca C Wade; M Paola Costi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-27       Impact factor: 11.205

7.  Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.

Authors:  P Deschamps; S Réty; J Bareille; N Leulliot
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-05-25       Impact factor: 1.056

8.  Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.

Authors:  Anna Tochowicz; Matteo Santucci; Puneet Saxena; Giambattista Guaitoli; Matteo Trande; Janet Finer-Moore; Robert M Stroud; Maria P Costi
Journal:  J Med Chem       Date:  2014-12-29       Impact factor: 7.446

9.  Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.

Authors:  Outi M H Salo-Ahen; Anna Tochowicz; Cecilia Pozzi; Daniela Cardinale; Stefania Ferrari; Yap Boum; Stefano Mangani; Robert M Stroud; Puneet Saxena; Hannu Myllykallio; Maria Paola Costi; Glauco Ponterini; Rebecca C Wade
Journal:  J Med Chem       Date:  2015-04-01       Impact factor: 7.446

10.  Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.

Authors:  Stephen Connelly; Jessica K DeMartino; Dale L Boger; Ian A Wilson
Journal:  Biochemistry       Date:  2013-07-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.